- •DeepSeek V4 Flash argues HOLD because The original swing recovery thesis remains intact despite the drawdown. Fresh catalysts — the $1.2B PrSM Increment 2 contract and $8-9B munitions investment — directly reinforce the defense-demand narrative that underpinned the entry. Lower-timeframe momentum is already repairing (30m bullish MACD zero-cross, 4h RSI rising), and the tight stop at $517.50 with 7.84 remaining R:R means the risk/reward strongly favors holding for the $538-$555 target with 23 calendar days remaining.
- •What changed: Comparison with entry (2026-09-23T14:50:02.791Z). Price: 530.5 to 521.63. Target progress: current -37.7%. Separately, historical maximum 2.1%; giveback from that maximum 39.9 percentage points. The peak's time is unavailable; it is not the prior-review observation. These are fractions of entry-to-target distance, not price returns. Change since entry: character calm -> No Edge; direction bullish -> bearish; risk low -> medium; confirmation yes -> no. The current regime observation is unconfirmed US-equity context. Source-claim novelty versus the prior review is unavailable. Packet novelty and publication dates do not establish when an event occurred.
The original swing recovery thesis remains intact despite the drawdown. Fresh catalysts — the $1.2B PrSM Increment 2 contract and $8-9B munitions investment — directly reinforce the defense-demand narrative that underpinned the entry. Lower-timeframe momentum is already repairing (30m bullish MACD zero-cross, 4h RSI rising), and the tight stop at $517.50 with 7.84 remaining R:R means the risk/reward strongly favors holding for the $538-$555 target with 23 calendar days remaining.
The core recovery thesis is still alive: price holds just above 1day support $517.22 and the $517.50 stop, 30m/4h momentum is repairing (30m bullish MACD zero-cross, RSI rising), and the fresh $1.2B PrSM Increment 2 production award plus $8-9B munitions capacity investment extend the same defense demand catalyst family that drove entry. LMT is also outperforming a falling XLI and HYG, refusing to follow the bearish sector/credit read-through. With remaining R:R still highly asymmetric to the $554 target and stop intact, the position deserves to stay open.
Lockheed Martin's original thesis remains intact due to material catalyst support, including a $1.2B U.S. Army contract for PrSM Increment 2 production and an $8B-$9B investment to accelerate munitions production. These developments align with the original thesis's emphasis on sustained platform demand and long-term revenue growth. While price has pulled back to the lower bound of the value area, it remains above critical support ($515.60) and the stop ($517.50), preserving the path to the $554 target. Short-term momentum is repairing, with RSI rising and a bullish MACD zero-cross on the 30-minute timeframe.
No model argued for EXIT.
- →Price breaks below the $517.50 stop and the $515.60-$517.22 support zone, confirming structural breakdown and invalidating the swing recovery thesis before the remaining 23-day horizon expires, as the daily bearish trend (RSI 38.53 falling, MACD negative falling) overwhelms the lower-timeframe momentum repair.
Individual Model Review
The core recovery thesis is still alive: price holds just above 1day support $517.22 and the $517.50 stop, 30m/4h momentum is repairing (30m bullish MACD zero-cross, RSI rising), and the fresh $1.2B PrSM Increment 2 production award plus $8-9B munitions capacity investment extend the same defense demand catalyst family that drove entry. LMT is also outperforming a falling XLI and HYG, refusing to follow the bearish sector/credit read-through. With remaining R:R still highly asymmetric to the $554 target and stop intact, the position deserves to stay open.
The core recovery thesis is still alive: price holds just above 1day support $517.22 and the $517.50 stop, 30m/4h momentum is repairing (30m bullish MACD zero-cross, RSI rising), and the fresh $1.2B PrSM Increment 2 production award plus $8-9B munitions capacity investment extend the same defense demand catalyst family that drove entry. LMT is also outperforming a falling XLI and HYG, refusing to follow the bearish sector/credit read-through. With remaining R:R still highly asymmetric to the $554 target and stop intact, the position deserves to stay open.
▼ Click to expandPrice has drawn down -1.7% below entry and now sits beneath the original $532.60 support anchor, with the regime flipped to unconfirmed bearish, direction bearish, confirmation lost, and multiple overhead barriers ($522.89 VAL, $526.52, $527.74 POC, $532.60) that must be reclaimed before the target. Depressed volume (percentile 18) and two HIGH-impact macro events within days raise the risk of a stop break before recovery, arguing the swing-recovery path has materially deteriorated.
▼ Click to expandThe original swing recovery thesis remains intact despite the drawdown. Fresh catalysts — the $1.2B PrSM Increment 2 contract and $8-9B munitions investment — directly reinforce the defense-demand narrative that underpinned the entry. Lower-timeframe momentum is already repairing (30m bullish MACD zero-cross, 4h RSI rising), and the tight stop at $517.50 with 7.84 remaining R:R means the risk/reward strongly favors holding for the $538-$555 target with 23 calendar days remaining.
The original swing recovery thesis remains intact despite the drawdown. Fresh catalysts — the $1.2B PrSM Increment 2 contract and $8-9B munitions investment — directly reinforce the defense-demand narrative that underpinned the entry. Lower-timeframe momentum is already repairing (30m bullish MACD zero-cross, 4h RSI rising), and the tight stop at $517.50 with 7.84 remaining R:R means the risk/reward strongly favors holding for the $538-$555 target with 23 calendar days remaining.
▼ Click to expandThe position is down -1.7% from entry and price has lost the original support thesis level at the $532.60 POC/value-area low. The daily trend remains bearish (RSI 38.53 falling, MACD negative falling) and the regime has shifted from calm/bullish to unconfirmed No Edge/bearish. Price sitting just below 4h resistance $521.90 with no confirmed acceptance means the path to target is blocked, and the macro headwinds from rising real yields and dollar strength could push LMT toward the $517.50 stop.
▼ Click to expandLockheed Martin's original thesis remains intact due to material catalyst support, including a $1.2B U.S. Army contract for PrSM Increment 2 production and an $8B-$9B investment to accelerate munitions production. These developments align with the original thesis's emphasis on sustained platform demand and long-term revenue growth. While price has pulled back to the lower bound of the value area, it remains above critical support ($515.60) and the stop ($517.50), preserving the path to the $554 target. Short-term momentum is repairing, with RSI rising and a bullish MACD zero-cross on the 30-minute timeframe.
Lockheed Martin's original thesis remains intact due to material catalyst support, including a $1.2B U.S. Army contract for PrSM Increment 2 production and an $8B-$9B investment to accelerate munitions production. These developments align with the original thesis's emphasis on sustained platform demand and long-term revenue growth. While price has pulled back to the lower bound of the value area, it remains above critical support ($515.60) and the stop ($517.50), preserving the path to the $554 target. Short-term momentum is repairing, with RSI rising and a bullish MACD zero-cross on the 30-minute timeframe.
▼ Click to expandThe exit case hinges on the breakdown of critical support at $515.60, which would trigger the stop at $517.50 and invalidate the original thesis. The unconfirmed US-equity context (observed 2026-09-28) suggests a bearish tilt, and the lack of confirmation from the sector (XLI) or broad tape (SPY, HYG) increases vulnerability to further downside if support fails. The pullback to the lower bound of the value area also raises the risk of a breakdown, particularly if the broader market weakness persists.
▼ Click to expandRun Summary
Intraday discovery triggered reanalysis on LMT. Verdict: HOLD (0/3 EXIT). Conviction: 67.